3B Medical Announces FDA Approval of New Auto Bi-level (BPAP) Device
LAKE WALES, Fla. (August 26, 2014)—3B Medical, Inc. announced FDA 510(k) clearance of the BPAP 25A. The BPAP 25A is full-featured Auto Bi-level device, offering features that help patients achieve better compliance and the provider improve its bottom line.
The BPAP 25A will come standard with advanced features like RESlex Exhalation Relief, a full range of pressure support, advanced clinical settings, and will integrate with 3B’s management system, iCodeConnect.
Commercial availability of the BPAP 25A is scheduled for October 1, 2014.
Post navigation
OUR DIGITAL PARTNERS


